On December 31, Gelonghui reported that Sichuan Goldstone (300434.SZ) announced that recently, its wholly-owned subsidiary, Zhejiang Deer Pharmaceutical Co., Ltd. (referred to as "Deer Pharmaceutical"), received the "Pharmaceutical GMP Compliance Inspection Notice" (No.: Zhe 2024 No. 0269) approved and issued by the Zhejiang Provincial Drug Administration.

Amorolfine Hydrochloride topical solution is a non-prescription drug used in dermatology for treating nail infections caused by sensitive fungi. Deer Pharmaceutical's Amorolfine Hydrochloride topical solution passed the drug review by the National Medical Products Administration in June 2006 and obtained the "Drug Registration Certificate". In December 2024, it passed the GMP compliance inspection of the topical preparation production line in the external preparation workshop.